ALC

#398
Alcon Inc. Ordinary Shares
66.2 8 USD
+0.49%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
66.19
66.70
Faixa anual
61.84
92.55
Mudança diária
+0.49%
Mudança mensal
-9.71%
Mudança em 6 meses
-16.39%
Mudança anual
-24.08%
Fechamento anterior
65.9 6
Open
66.4 2
Mínimo
66.1 9
High
66.7 0
Volume
2 248
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas Dividendos
Trimestral Ano
  • Market Capitalization 32.31 B
  • Employee 26 K
  • Founded N/A
  • CEO David J. Endicott
  • Website www.alcon.com
  • Headquarter Switzerland
  • FIGI UNKNOWN
  • Industry Instrumentos médicos e consumíveis
Receita total
Lucro líquido
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa

Alcon Inc. Ordinary Shares

Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people. Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies.

Notícias